Overview

A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents

Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to describe the pharmacokinetic profiles of VI-0521 in obese adolescents.
Phase:
Phase 4
Details
Lead Sponsor:
VIVUS, Inc.
Treatments:
Phentermine
Topiramate